Text

New Frontier in Fight Against Rare Disease

Date posted: November 1, 2021

Text

Nancy Mendelsohn, MD, chief medical officer for Optum Frontier Therapies and senior vice president, medical affairs, genetics and rare disease for UnitedHealth Group, authored the article "A New Frontier in the Fight Against Rare Disease," featured in Pharmacy Times.

Text

Compassionate service and support

The piece highlights the importance of providing higher levels of service and support to people living with rare disease. Also critical is the role of collaboration among pharmaceutical manufacturers, providers and payers.

As we look ahead, the industry will need to focus on building new benefit models for rare disease, improving access to genomic testing, and helping with affordability, among other priorities.

But above all, Mendelsohn writes, it is imperative that we support patients and their families with compassion while creating access to these innovative therapies.

Read the article.

Text

Text

achc gold seal

Text

Text